JP2012528824A5 - - Google Patents

Download PDF

Info

Publication number
JP2012528824A5
JP2012528824A5 JP2012513590A JP2012513590A JP2012528824A5 JP 2012528824 A5 JP2012528824 A5 JP 2012528824A5 JP 2012513590 A JP2012513590 A JP 2012513590A JP 2012513590 A JP2012513590 A JP 2012513590A JP 2012528824 A5 JP2012528824 A5 JP 2012528824A5
Authority
JP
Japan
Prior art keywords
methyl
benzamide
phenyl
compound
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2012513590A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012528824A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2010/057598 external-priority patent/WO2010139678A1/en
Publication of JP2012528824A publication Critical patent/JP2012528824A/ja
Publication of JP2012528824A5 publication Critical patent/JP2012528824A5/ja
Withdrawn legal-status Critical Current

Links

JP2012513590A 2009-06-02 2010-06-01 アルファ−炭酸脱水酵素アイソフォームにより媒介される哺乳動物の障害の処置 Withdrawn JP2012528824A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP09161720.9 2009-06-02
EP09161720 2009-06-02
PCT/EP2010/057598 WO2010139678A1 (en) 2009-06-02 2010-06-01 Treatment of mammalian disorders mediated by alpha-carbonic anhydrase isoforms

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2015189993A Division JP2016020375A (ja) 2009-06-02 2015-09-28 アルファ−炭酸脱水酵素アイソフォームにより媒介される哺乳動物の障害の処置

Publications (2)

Publication Number Publication Date
JP2012528824A JP2012528824A (ja) 2012-11-15
JP2012528824A5 true JP2012528824A5 (cg-RX-API-DMAC7.html) 2013-07-18

Family

ID=40902237

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2012513590A Withdrawn JP2012528824A (ja) 2009-06-02 2010-06-01 アルファ−炭酸脱水酵素アイソフォームにより媒介される哺乳動物の障害の処置
JP2015189993A Ceased JP2016020375A (ja) 2009-06-02 2015-09-28 アルファ−炭酸脱水酵素アイソフォームにより媒介される哺乳動物の障害の処置
JP2017146753A Withdrawn JP2017203037A (ja) 2009-06-02 2017-07-28 アルファ−炭酸脱水酵素アイソフォームにより媒介される哺乳動物の障害の処置

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2015189993A Ceased JP2016020375A (ja) 2009-06-02 2015-09-28 アルファ−炭酸脱水酵素アイソフォームにより媒介される哺乳動物の障害の処置
JP2017146753A Withdrawn JP2017203037A (ja) 2009-06-02 2017-07-28 アルファ−炭酸脱水酵素アイソフォームにより媒介される哺乳動物の障害の処置

Country Status (5)

Country Link
US (1) US9623025B2 (cg-RX-API-DMAC7.html)
EP (1) EP2437745B1 (cg-RX-API-DMAC7.html)
JP (3) JP2012528824A (cg-RX-API-DMAC7.html)
TW (2) TW201102068A (cg-RX-API-DMAC7.html)
WO (2) WO2010141427A1 (cg-RX-API-DMAC7.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101386697B1 (ko) * 2012-06-18 2014-04-18 아주대학교산학협력단 이매티닙 또는 이의 약학적으로 허용되는 염을 유효성분으로 포함하는 혈관 투과성 관련 질환의 치료 또는 예방용 조성물
KR101778004B1 (ko) * 2015-06-22 2017-09-15 (주) 에빅스젠 이마티닙을 유효성분으로 포함하는 안구 건조 질환 예방 및 치료용 약학 조성물
US11439869B2 (en) 2017-05-19 2022-09-13 Trudell Medical International Positive expiratory pressure device
USD874064S1 (en) 2018-05-18 2020-01-28 Trudell Medical International Mask
USD903097S1 (en) 2018-05-18 2020-11-24 Trudell Medical International Mask
CN115569137A (zh) 2018-06-15 2023-01-06 汉达癌症医药责任有限公司 激酶抑制剂的盐类及其组合物
USD893806S1 (en) 2018-11-09 2020-08-18 Trudell Medical Internationl Mask and shroud

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW225528B (cg-RX-API-DMAC7.html) 1992-04-03 1994-06-21 Ciba Geigy Ag
US5521184A (en) 1992-04-03 1996-05-28 Ciba-Geigy Corporation Pyrimidine derivatives and processes for the preparation thereof
US5798380A (en) * 1996-02-21 1998-08-25 Wisconsin Alumni Research Foundation Cytoskeletal active agents for glaucoma therapy
CO4940418A1 (es) * 1997-07-18 2000-07-24 Novartis Ag Modificacion de cristal de un derivado de n-fenil-2- pirimidinamina, procesos para su fabricacion y su uso
WO2003072090A2 (en) 2002-02-27 2003-09-04 Ab Science Use of tyrosine kinase inhibitors for treating cns disorders
GB0215676D0 (en) * 2002-07-05 2002-08-14 Novartis Ag Organic compounds
WO2005107708A1 (en) * 2004-04-30 2005-11-17 Allergan, Inc. Biodegradable intravitreal tyrosine kinase inhibitors implants
RU2430727C2 (ru) * 2005-06-03 2011-10-10 Новартис Аг Комбинация производных пиримидиламинобензамида и иматиниба для лечения или профилактики пролиферативных заболеваний
GT200600316A (es) 2005-07-20 2007-04-02 Sales de 4-metilo-n-(3-(4-metilo-imidazol-1-ilo)-5-trifluorometilo-fenilo)-3-(4-piridina-3-ilo-pirimidina-2-iloamino)- benzamida.
GT200600315A (es) 2005-07-20 2007-03-19 Formas cristalinas de 4-metilo-n-[3-(4-metilo-imidazol-1-ilo)-5-trifluorometilo-fenilo]-3-(4-pyridina-3-ilo-pirimidina-2-iloamino)-benzamida
EA019595B1 (ru) * 2007-04-17 2014-04-30 Имклоун Элэлси СПЕЦИФИЧНЫЕ ИНГИБИТОРЫ PDGFRβ
PE20090368A1 (es) * 2007-06-19 2009-04-28 Boehringer Ingelheim Int Anticuerpos anti-igf
JP6623812B2 (ja) * 2016-02-17 2019-12-25 セイコーエプソン株式会社 位置検出装置、及び、そのコントラスト調整方法

Similar Documents

Publication Publication Date Title
JP2016020375A5 (cg-RX-API-DMAC7.html)
JP2012528824A5 (cg-RX-API-DMAC7.html)
RU2458920C2 (ru) Новые соединения
JP2013543896A5 (cg-RX-API-DMAC7.html)
JP2017504611A5 (cg-RX-API-DMAC7.html)
JP2016505637A5 (cg-RX-API-DMAC7.html)
JP2007519754A5 (cg-RX-API-DMAC7.html)
BR112013032122A2 (pt) liberação modificada de 4-metil-3-[[4-(3-piridinil)-2-pirimidinil]amino]-n-[5-(4-metil-1h-imidazol-1-il)-3-(trifluorometil)fenil] benzamida solubilizada usando ácidos orgânicos
JP2007519649A5 (cg-RX-API-DMAC7.html)
JP2018537507A5 (cg-RX-API-DMAC7.html)
JP2013529210A5 (cg-RX-API-DMAC7.html)
RU2017120217A (ru) 2-амино-5,5-дифтор-6-(фторметил)-6-фенил-3,4,5,6-тетрагидпропиридины в качестве ингибиторов bace1
JP2017528507A5 (cg-RX-API-DMAC7.html)
JP2011529037A5 (cg-RX-API-DMAC7.html)
JP2015524472A5 (cg-RX-API-DMAC7.html)
JP2016027060A5 (cg-RX-API-DMAC7.html)
ME03723B (me) 2-amin0-6-(difluorometil)- 5,5-difluoro-6-fenil-3,4,5,6-tetrahidropiridini kао васе1 inhibiтori
JP2009532438A5 (cg-RX-API-DMAC7.html)
JP2012515788A5 (cg-RX-API-DMAC7.html)
JP2013544811A5 (cg-RX-API-DMAC7.html)
JP2016540811A5 (cg-RX-API-DMAC7.html)
MX2021010133A (es) Forma cristalina de 1-(1-oxo-1,2-dihidroisoquinolin-5-il)-5-(trifl uorometil)-n-(2-(trifluorometil)piridin-4-il)-1h-pirazol-4-carbox amida monohidratada.
RU2014144951A (ru) Новое 1-замещенное производное индазола
JP2009501745A5 (cg-RX-API-DMAC7.html)
JP2015522606A5 (cg-RX-API-DMAC7.html)